We are proud to share that Linio Biotech and our regenerative platform technology, Tience®, have been featured in Aftonbladet, Sweden’s largest daily newspaper.

The article highlights the growing shift in aesthetic medicine from traditional fillers and Botox toward regenerative skin treatments and presents Tience® as a truly science-driven, cell-free injectable based on isolated bioactive components from adipose tissue. Designed to activate the skin’s natural repair mechanisms, Tience® supports collagen production, healing, and long-term skin quality rather than simply adding volume.

Being recognized in Sweden’s leading newspaper highlights what makes Tience® unique: it represents a new category in regenerative aesthetics, one focused on strengthening and restoring the skin through advanced biotechnology.

Stockholm-based dermatologist Anne Wetter, who performs Tience® treatments, emphasizes in the article that the method is not a quick fix or volumizing solution. Instead, it is intended to strengthen thin and fragile skin and improve skin quality for patients who want healthier skin, not altered facial features.

We are honored to see our regenerative innovation gaining broader visibility and creating this important shift in aesthetic medicine.

Read the full article here.